| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
NEUREN PHARMACEUTICALS LIMITED (NEU)
Stock Code: NEU
Listing Date: 2005-02-03 00:00:00
Website: http://www.neurenpharma.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Biopharmaceutical company with a focus on neuroprotection and metabolism.
Address:
122 Arthur Street, C/o Barnes Dowell James
NORTH SYDNEY
NSW 2060
Phone: +64 9 529 3942
Fax: +64 9 529 3941
Executives & Directors
Dr Robin Congreve, Chairman
Dr Parmjot Bains, CEO
Mr Larry Glass, CEO
Mr Tom Amos, Non Exec. Director
Mr Trevor Scott, Non Exec. Director
Dr Douglas Wilson, Non Exec. Director
Dr Graeme Howie, Non Exec. Director
Mr Rob Turnbull, CFO
Mr Robert Waring, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
NEU - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO
|
Wed, 14 Feb 2007 01:30PM |
|
| Interim Results | Fri, 29 Aug 2008 | |
| Annual General Meeting | Thu, 29 May 2008 12:30PM |
|
| Full Year Results | Fri, 29 Feb 2008 | |
| EGM | Fri, 12 Oct 2007 12:30PM |
|
| Interim Results | Fri, 31 Aug 2007 | |
| Annual General Meeting | Wed, 23 May 2007 12:30AM |
|
| Full Year Results | Fri, 16 Mar 2007 | |
| Interim Results | Tue, 12 Sep 2006 | |
| Annual General Meeting | Wed, 3 May 2006 12:00AM |
|
| Full Year Results | Tue, 28 Feb 2006 | |
| Annual General Meeting | Mon, 30 May 2005 12:30PM |
NEUREN PHARMACEUTICALS LIMITED (NEU)
| Change of Director`s Interest Notice | Tue, 30 Sep 2008 |
| Appendix 3B | Tue, 30 Sep 2008 |
| Neuren raises $2m through underwritten SPP | Tue, 30 Sep 2008 |
| US Army to provide additional NNZ2566 trial funding | Thu, 4 Sep 2008 |
| Half Yearly Report and Accounts | Fri, 29 Aug 2008 |
| Results of Special Shareholders` Meeting | Thu, 28 Aug 2008 |
| Neuren signs cancer license and collaboration agreement | Wed, 27 Aug 2008 |
| Neuren extends SPP closing date | Wed, 27 Aug 2008 |
| NZ Securities Act certification for SPP | Thu, 21 Aug 2008 |
| Notice under section 708A(5)(e) of the Corporations Act | Fri, 15 Aug 2008 |
| Share Purchase Plan letter to eligible shareholders | Fri, 15 Aug 2008 |
| Notice of Special Meeting | Tue, 12 Aug 2008 |
| Change in substantial holding | Tue, 12 Aug 2008 |
| Reinstatement to Official Quotation | Wed, 6 Aug 2008 |
| Neuren raises a minimum of $3 million | Wed, 6 Aug 2008 |
| Appendix 3B | Wed, 6 Aug 2008 |
| Neuren Share Purchase Plan | Wed, 6 Aug 2008 |
| Voluntary Suspension extended | Mon, 4 Aug 2008 |
| Suspension from Official Quotation | Thu, 31 Jul 2008 |
| Appendix 4C - quarterly | Thu, 31 Jul 2008 |
| Trading Halt | Tue, 29 Jul 2008 |
| Glypromate and NNZ 2566 in Top 10 Neuroscience Projects | Mon, 21 Jul 2008 |
| NEU Completes Glypromate Phase 3 Recruitment | Wed, 16 Jul 2008 |
| Neuren to get early results from Glypromate trial | Mon, 30 Jun 2008 |
| CEO presentation to AGM | Thu, 29 May 2008 |
| Results of Meeting | Thu, 29 May 2008 |
| Response to ASX Query re: Appendix 4C | Mon, 26 May 2008 |
| Positive interim safety analysis for Glypromate | Thu, 15 May 2008 |
| Appendix 4C - quarterly | Wed, 30 Apr 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 29 Apr 2008 |
| Quarterly Update to Shareholders April 2008 | Tue, 29 Apr 2008 |
| Change of Share Registry Address | Wed, 23 Apr 2008 |
| Annual Report to shareholders | Mon, 31 Mar 2008 |
| Co-CEOs remuneration packages | Tue, 18 Mar 2008 |
| Appendix 4E Preliminary Final Report | Fri, 29 Feb 2008 |
| Appendix 3B | Tue, 26 Feb 2008 |
| Form 604 | Mon, 18 Feb 2008 |
| Becoming a substantial holder | Wed, 13 Feb 2008 |
| Substantial shareholder notice | Mon, 11 Feb 2008 |
| Rights issue raises $7.1m and notes convert | Mon, 11 Feb 2008 |
| Change of Director`s Interest Notice | Mon, 11 Feb 2008 |
| Appendix 3B - shares issued on conversion of notes | Thu, 7 Feb 2008 |
| Change in substantial holding | Thu, 7 Feb 2008 |
| Appendix 3B - allotment of rights issue underwriter shares | Thu, 7 Feb 2008 |
| Notice under section 708A(5)(e) | Tue, 5 Feb 2008 |
| Appendix 3B - allotment of rights issue shares | Fri, 1 Feb 2008 |
| Results of Rights Issue | Thu, 31 Jan 2008 |
| Neuren Appendix 4C December 2007 | Thu, 31 Jan 2008 |
| Foreign Shareholder Notice re Rights Issue | Wed, 19 Dec 2007 |
| Optionholder Notice re Rights Issue | Wed, 19 Dec 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.